Track the Integrum AB stock price and the full insider trade history of the company, a listed equity based in Finland. Shares are listed on the FI market, under the oversight of FIN-FSA. Operating in the Health Care sector, Integrum AB has recorded 12 insider filings. Market capitalisation: €234.1m. The latest transaction was filed on 8 July 2026 (Purchase). Among the most active insiders: Kristofer Westergren. Every trade is openly available.
12
Insider Decl.
n/a
Thresholds
€700,106
8 ops.
Buy Volume
n/a
2 ops.
Sell Volume
32Σ signal
Buys €700,106n/a Sells
Fundamental score
Ranked 26,073 of 28,803 companies
21.3
score / 100
Value
9
Quality
33
FCF yld-26%
Earn yld-21%
EV/EBITDA·
ROE-27%
Gross mgn69%
Net mgn-51%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Integrum AB is a company in the health and pharmaceutical sector, focused on developing innovative solutions for medical care. It is listed on the XSTO exchange.